{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 444401508
| IUPAC_name = 1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol
| image = Naftopidil.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|naftopidil}}
| pregnancy_category =  
| legal_status = Rx-only
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 57149-07-2
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 4418
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = R9PHW59SFN
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 4265

<!--Chemical data-->
| C=24 | H=28 | N=2 | O=3 
| molecular_weight = 392.49 g/mol
| smiles = COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = HRRBJVNMSRJFHQ-UHFFFAOYSA-N

}}

'''Naftopidil''' ([[International Nonproprietary Name|INN]], marketed under the brand name '''Flivas''') is a drug used in  benign prostatic hypertrophy which acts as a [[binding selectivity|selective]] [[alpha-1 adrenergic receptor|α<sub>1</sub>-adrenergic receptor]] [[receptor antagonist|antagonist]] or [[alpha blocker]].<ref>{{cite journal |title = Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication |vauthors=Sakai H, Igawa T, Onita T, Furukawa M, Hakariya T, Hayashi M, Matsuya F, Shida Y, Nishimura N, Yogi Y, Tsurusaki T, Takehara K, Nomata K, Shiraishi K, Shono T, Aoki D, Kanetake H |journal = Hinyokika Kiyo. |year = 2011 |volume = 57 |pages = 7–13 |pmid=21304253 |issue=1}}</ref>

== See also ==
* [[Urapidil]]

== References ==
{{Reflist}}

{{Antihypertensives}}
{{Adrenergics}}

[[Category:Calcium channel blockers]]
[[Category:Antihypertensive agents]]
[[Category:Naphthol ethers]]
[[Category:Alcohols]]
[[Category:Piperazines]]


{{antihypertensive-stub}}